Atlas Trials

Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer

Clinical trial NCT00017394 · COMPLETED

Trial details

NCT number
NCT00017394
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
Start date
2001-03-01
Primary completion
2007-09-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.